Brief: Belite Bio May Offer And Sell ADSs Having An Aggregate Offering Price Of Up To $100 Mln
16/06/2023 21:56
June 16 (Reuters) - Belite Bio Inc BLTE.O :
* BELITE BIO INC- MAY OFFER AND SELL ADSS HAVING AN
AGGREGATE
OFFERING PRICE OF UP TO $100 MILLION FROM TIME TO TIME
Source text for Eikon: ID:
Further company coverage: BLTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Belite Bio
See all newsBrief: Belite Bio Announces Uplisting To The Nasdaq Global Select Market
Brief: Belite Bio Announces Multi-Market Submission Of Marketing Authorization Applications Via The Access Consortium Pathway For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Brief: Belite Bio Announces Submission Of New Drug Application To The Ministry Of Health, Labour, And Welfare In Japan Under The Sakigake Designation System For Tinlarebant For The Treatment Of Stargardt Disease Type 1
Belite Bio, Inc reports results for the quarter ended June 30 - Earnings Summary
Belite Bio Q2 net loss widens on higher expenses